Covered recipient · General Payments record
WADE T MCCOY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,787.02
- Reported across 186 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $524.05 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $215.17 | 14 |
| Acerta Pharma LLC | $105.38 | 1 |
| GlaxoSmithKline, LLC. | $73.80 | 5 |
| Medtronic, Inc. | $31.72 | 2 |
| DEXCOM, INC. | $28.21 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.63 | 1 |
| Merck Sharp & Dohme Corporation | $17.68 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.72 | 1 |
| Astellas Pharma US Inc | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.48 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997867 | CMS |
| ABBVIE INC. | $31.76 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997869 | CMS |
| ABBVIE INC. | $9.77 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997871 | CMS |
| ABBVIE INC. | $9.95 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997873 | CMS |
| ABBVIE INC. | $9.41 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997875 | CMS |
| ABBVIE INC. | $9.92 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997877 | CMS |
| ABBVIE INC. | $9.14 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997879 | CMS |
| ABBVIE INC. | $20.66 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997881 | CMS |
| ABBVIE INC. | $33.80 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997883 | CMS |
| ABBVIE INC. | $34.86 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997885 | CMS |
| ABBVIE INC. | $8.79 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997887 | CMS |
| ABBVIE INC. | $9.06 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997889 | CMS |
| ABBVIE INC. | $7.19 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997891 | CMS |
| ABBVIE INC. | $14.38 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104997893 | CMS |
| Astellas Pharma US Inc | $13.74 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139328076 | CMS |
| AstraZeneca Pharmaceuticals LP | $105.38 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104273529 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.72 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117907746 | CMS |
| Dexcom, Inc. | $28.21 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153343371 | CMS |
| GlaxoSmithKline, LLC. | $14.70 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116576082 | CMS |
| GlaxoSmithKline, LLC. | $14.74 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116443043 | CMS |
| GlaxoSmithKline, LLC. | $14.13 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116621839 | CMS |
| GlaxoSmithKline, LLC. | $16.05 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116372515 | CMS |
| GlaxoSmithKline, LLC. | $14.18 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116136166 | CMS |
| Medtronic, Inc. | $15.82 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117100681 | CMS |
| Medtronic, Inc. | $15.90 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117100683 | CMS |
| Merck Sharp & Dohme LLC | $17.68 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141567500 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.63 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118938958 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.